Doxycycline Hyclate Tablet · 6 active FDA presentation rows for this drug
FDA lists Doxycycline Hyclate Tablet as To Be Discontinued (Mylan Pharmaceuticals Inc., a Viatris Company).
No availability text on this FDA row.
Doxycycline Hyclate Tablet: To Be Discontinued
FDA availability text is not recorded on this row. 6 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Doxycycline Hyclate Tablet
- Manufacturer
- Mylan Pharmaceuticals Inc., a Viatris Company
- Dosage Form
- Tablet
- Presentation
- Doxycycline Hyclate, Tablet, 100 mg (NDC 0378-0167-02)
- Package NDC
- 0378-0167-02
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jan 12, 2026
- Last Updated
- Jan 12, 2026
- Therapeutic Category
- Anti-Infective
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Full Drug Profile
doxycycline
Side effects, interactions, warnings & more
Nearby, Other Doxycycline Shortage Records
Doxycycline Hyclate Tablet
Teva Pharmaceuticals USA, Inc.
Tablet
Doxycycline Hyclate Tablet
Teva Pharmaceuticals USA, Inc.
Tablet
Doxycycline Hyclate Tablet
Teva Pharmaceuticals USA, Inc.
Tablet
Doxycycline Hyclate Tablet
Teva Pharmaceuticals USA, Inc.
Tablet
Doxycycline Hyclate Tablet
Mylan Pharmaceuticals Inc., a Viatris Company
Tablet
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.